Меню
Идёт набор NCT06858449

Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

Без фазы С лечением Cancer Breast Cancer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Whey protein (20 grams), Whey protein (60 grams).
Кому может быть актуально
Состояния в реестре: Cancer, Breast Cancer. Базовые параметры: 20 лет — 89 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

NeoChemoPRT: A Randomized Study of Resistance Training and Post-Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

Обзор

In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.

Вмешательства

  • Пищевая добавка Whey protein (20 grams)
    20 grams of whey protein
  • Пищевая добавка Whey protein (60 grams)
    60 grams of whey protein.

Первичные конечные точки

  • Changes in muscle mass and fat mass (pounds) at completion of chemotherapy [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
Вторичные конечные точки (10)
  • Response to Chemotherapy Assed Via the Guidelines or the Response evaluation criteria in solid tumors (RECIST) [Срок оценки: Chemotherapy response assessment is at program completion (within 4 weeks of exercise completion)]
  • Changes in EuroQol-5 Dimensions (EQ-5D) at completion of chemotherapy assessment [Срок оценки: Baseline assessment (prior to program) and at exercise program completion (at 24 weeks).]
  • Changes in Patient Health Questionnaire-9 (PHQ9) depression score at completion of chemotherapy assessment [Срок оценки: Baseline assessment (prior to program) and at exercise program completion (at 24 weeks).]
  • Changes in General Anxiety Disorder-7 (GAD7) anxiety score at completion of chemotherapy assessment [Срок оценки: Baseline assessment (prior to program) and at exercise program completion (at 24 weeks).]
  • Changes in activity levels via Godin Leisure-Time Exercise Questionnaire [Срок оценки: Baseline assessment (prior to program) and at exercise program completion (at 24 weeks).]
  • Changes in resting metabolic rate at completion of chemotherapy [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
  • Changes in body composition at completion of chemotherapy, including fat-free mass in pounds. [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
  • Changes in Y-Balance Test Scores at baseline and at completion of chemotherapy [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
  • Changes in Functional Mobility Score at baseline and at completion of chemotherapy [Срок оценки: Baseline and at program completion (within 4 weeks of exercise completion).]
  • Changes in phase angle at completion of chemotherapy [Срок оценки: At program completion (at 24 weeks)]

Критерии участия

Критерии включения

  • Age 20-89 years
  • Women with a biopsy proven diagnosis of invasive carcinoma of the breast.
  • Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery
  • Must be able to read and understand English and consent for themselves.

Критерии исключения

  • Inability to get up and down off the ground or squat body weight
  • Inability to safely engage in group exercise sessions as deemed by study PI
  • Severe arthritic, joint, cardiovascular, musculoskeletal, or any other condition deemed by PI to be unsafe to engage in resistance training
  • Lactose intolerance
  • Cow's milk or whey protein allergy
  • Pregnant women
  • Males

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Другое

Центры проведения

США · 1 центр
  • Allegheny General Hospital — Pittsburgh

Идентификаторы

NCT: NCT06858449 · 2024-149-SG

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗